Home >> Research Area >>Tyrosine Kinase/Adaptors>>FLT3>> 5'-Fluoroindirubinoxime

5'-Fluoroindirubinoxime

FLT3 inhibitor; displays antiproliferative activity CAS# 861214-33-7

5'-Fluoroindirubinoxime

2D Structure

Catalog No. BCC6104----Order now to get a substantial discount!

Product Name & Size Price Stock
5'-Fluoroindirubinoxime: 5mg $81 In Stock
5'-Fluoroindirubinoxime: 10mg Please Inquire In Stock
5'-Fluoroindirubinoxime: 20mg Please Inquire Please Inquire
5'-Fluoroindirubinoxime: 50mg Please Inquire Please Inquire
5'-Fluoroindirubinoxime: 100mg Please Inquire Please Inquire
5'-Fluoroindirubinoxime: 200mg Please Inquire Please Inquire
5'-Fluoroindirubinoxime: 500mg Please Inquire Please Inquire
5'-Fluoroindirubinoxime: 1000mg Please Inquire Please Inquire
Related Products

Quality Control of 5'-Fluoroindirubinoxime

3D structure

Package In Stock

5'-Fluoroindirubinoxime

Number of papers citing our products

Chemical Properties of 5'-Fluoroindirubinoxime

Cas No. 861214-33-7 SDF Download SDF
PubChem ID 11580208 Appearance Powder
Formula C16H10FN3O2 M.Wt 295.27
Type of Compound N/A Storage Desiccate at -20°C
Solubility DMSO : 83.33 mg/mL (282.22 mM; Need ultrasonic)
Chemical Name 5-fluoro-3-[3-(hydroxyamino)-1H-indol-2-yl]indol-2-one
SMILES C1=CC=C2C(=C1)C(=C(N2)C3=C4C=C(C=CC4=NC3=O)F)NO
Standard InChIKey LBUXOYSDWHGJNP-UHFFFAOYSA-N
Standard InChI InChI=1S/C16H10FN3O2/c17-8-5-6-12-10(7-8)13(16(21)19-12)15-14(20-22)9-3-1-2-4-11(9)18-15/h1-7,18,20,22H
General tips For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.
We recommend that you prepare and use the solution on the same day. However, if the test schedule requires, the stock solutions can be prepared in advance, and the stock solution must be sealed and stored below -20℃. In general, the stock solution can be kept for several months.
Before use, we recommend that you leave the vial at room temperature for at least an hour before opening it.
About Packaging 1. The packaging of the product may be reversed during transportation, cause the high purity compounds to adhere to the neck or cap of the vial.Take the vail out of its packaging and shake gently until the compounds fall to the bottom of the vial.
2. For liquid products, please centrifuge at 500xg to gather the liquid to the bottom of the vial.
3. Try to avoid loss or contamination during the experiment.
Shipping Condition Packaging according to customer requirements(5mg, 10mg, 20mg and more). Ship via FedEx, DHL, UPS, EMS or other couriers with RT, or blue ice upon request.

Biological Activity of 5'-Fluoroindirubinoxime

DescriptionInhibitor of FMS-like receptor tyrosine kinase-3 (FLT3) (IC50 = 15 nM). Displays selectivity for FLT3 against 6 other kinases including EGFR. Displays antiproliferative activity against the MV4;11 cell line (expressing constitutively active FLT3) and a number of cancer cell lines, including SNU-638 (stomach carcinoma) and HT-1080 (fibrosarcoma).

5'-Fluoroindirubinoxime Dilution Calculator

Concentration (start)
x
Volume (start)
=
Concentration (final)
x
Volume (final)
 
 
 
C1
V1
C2
V2

calculate

5'-Fluoroindirubinoxime Molarity Calculator

Mass
=
Concentration
x
Volume
x
MW*
 
 
 
g/mol

calculate

Preparing Stock Solutions of 5'-Fluoroindirubinoxime

1 mg 5 mg 10 mg 20 mg 25 mg
1 mM 3.3867 mL 16.9337 mL 33.8673 mL 67.7346 mL 84.6683 mL
5 mM 0.6773 mL 3.3867 mL 6.7735 mL 13.5469 mL 16.9337 mL
10 mM 0.3387 mL 1.6934 mL 3.3867 mL 6.7735 mL 8.4668 mL
50 mM 0.0677 mL 0.3387 mL 0.6773 mL 1.3547 mL 1.6934 mL
100 mM 0.0339 mL 0.1693 mL 0.3387 mL 0.6773 mL 0.8467 mL
* Note: If you are in the process of experiment, it's necessary to make the dilution ratios of the samples. The dilution data above is only for reference. Normally, it's can get a better solubility within lower of Concentrations.

Organizitions Citing Our Products recently

 
 
 

Calcutta University

University of Minnesota

University of Maryland School of Medicine

University of Illinois at Chicago

The Ohio State University

University of Zurich

Harvard University

Colorado State University

Auburn University

Yale University

Worcester Polytechnic Institute

Washington State University

Stanford University

University of Leipzig

Universidade da Beira Interior

The Institute of Cancer Research

Heidelberg University

University of Amsterdam

University of Auckland
TsingHua University
TsingHua University
The University of Michigan
The University of Michigan
Miami University
Miami University
DRURY University
DRURY University
Jilin University
Jilin University
Fudan University
Fudan University
Wuhan University
Wuhan University
Sun Yat-sen University
Sun Yat-sen University
Universite de Paris
Universite de Paris
Deemed University
Deemed University
Auckland University
Auckland University
The University of Tokyo
The University of Tokyo
Korea University
Korea University
Featured Products
New Products
 

References on 5'-Fluoroindirubinoxime

Indirubin derivatives as potent FLT3 inhibitors with anti-proliferative activity of acute myeloid leukemic cells.[Pubmed:20153646]

Bioorg Med Chem Lett. 2010 Mar 15;20(6):2033-7.

Indirubin derivatives were identified as potent FLT3 tyrosine kinase inhibitors with anti-proliferative activity at acute myeloid leukemic cell lines, RS4;11 and MV4;11 which express FLT3-WT and FLT3-ITD mutation, respectively. Among several 5 and 5'-substituted indirubin derivatives, 5-fluoro analog, 13 exhibited potent inhibitory activity at FLT3 (IC(50)=15 nM) with more than 100-fold selectivity versus 6 other kinases and potent anti-proliferative effect for MV4;11 cells (IC(50)=72 nM) with 30-fold selectivity versus RS4;11 cells. Cell cycle analysis indicated that compound 13 induced cell cycle arrest at G(0)/G(1) phase in MV4;11 cells.

Inhibition of Toxoplasma gondii by indirubin and tryptanthrin analogs.[Pubmed:18824607]

Antimicrob Agents Chemother. 2008 Dec;52(12):4466-9.

New drugs are needed for treatment of Toxoplasma gondii infections. We tested derivatives of principles found in Isatis indigotica for in vitro efficacy against T. gondii infection. Indirubin-3'-oxime analogs showed modest micromolar activity, while tryptanthrin derivatives displayed 50% inhibitory doses in the low nanomolar range. Tryptanthrins have potential as anti-Toxoplasma infection therapeutics.

Antitumor activity of novel indirubin derivatives in rat tumor model.[Pubmed:17200363]

Clin Cancer Res. 2007 Jan 1;13(1):253-9.

PURPOSE: The novel indirubin derivatives 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime were designed and tested for antitumor activity both in vitro and in vivo using rat tumor model. EXPERIMENTAL DESIGN: Three-week-old male Sprague-Dawley rats were inoculated s.c. on the left flank with 10(7) RK3E-ras rat kidney epithelial cells harboring k-ras gene. Alternatively, 5 x 10(6) RK3E-ras cells were injected into the oral mucosa. Indirubin derivative treatment began on the 3rd or 6th day after oral or s.c. cell injection, respectively. Indirubin derivatives were directly injected into the tumor every other day for a total of five times. Animals were monitored daily and tumor volume was measured by caliper. RESULTS: Indirubin derivatives showed potent antiproliferative activity on various human cancer cells and oncogenic RK3E-ras rat kidney cells, with IC(50) ranging from 1 to 12 mumol/L. Treatment with indirubin derivatives induced the activation of caspase-7 followed by apoptosis in RK3E-ras cells. Indirubin derivatives showed strong antitumor activity in rat solid and oral tumor models. Direct injection of indirubin derivatives every other day for 10 days induced significant inhibition of tumor growth in Sprague-Dawley rats bearing RK3E-ras-induced tumors. Histologically, treatment with indirubin derivatives caused significant inhibition of tumor formation with increased apoptosis and decreased tumor cell proliferation. CONCLUSIONS: Our data showed that novel indirubin derivatives 5'-nitro-indirubinoxime, 5'-fluoro-indirubinoxime, and 5'-trimethylacetamino-indirubinoxime effectively arrested the tumor growth by inhibiting cell proliferation and inducing apoptosis. These findings provide the potential value of indirubin derivatives as novel candidates for antitumor agents.

Description

5'-Fluoroindirubinoxime (5’-FIO, compound 13), an Indirubin (HY-N0117) derivative, is a potent FLT3 inhibitor, with an IC50 of 15 nM.

Keywords:

5'-Fluoroindirubinoxime,861214-33-7,Natural Products,FLT3, buy 5'-Fluoroindirubinoxime , 5'-Fluoroindirubinoxime supplier , purchase 5'-Fluoroindirubinoxime , 5'-Fluoroindirubinoxime cost , 5'-Fluoroindirubinoxime manufacturer , order 5'-Fluoroindirubinoxime , high purity 5'-Fluoroindirubinoxime

Online Inquiry for:

      Fill out the information below

      • Size:Qty: - +

      * Required Fields

                                      Result: